These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21939623)

  • 21. Molecular phenotypes of atherosclerosis: fingering the perpetrators.
    Davies PF
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1746-7. PubMed ID: 15472136
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population.
    Jung ES; Kim SW; Moon CM; Shin DJ; Son NH; Kim ES; Lee HJ; Hong SP; Kim TI; Kim WH; Cheon JH
    Life Sci; 2011 Aug; 89(9-10):289-94. PubMed ID: 21763322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding association and causality in the genetic studies of inflammatory bowel disease.
    Trinh TT; Rioux JD
    Gastroenterology; 2005 Dec; 129(6):2106-10. PubMed ID: 16344078
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular biology of dysplasia and cancer in inflammatory bowel disease.
    Itzkowitz SH
    Gastroenterol Clin North Am; 2006 Sep; 35(3):553-71. PubMed ID: 16952740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional SFTPD gene variants are not associated with susceptibility to inflammatory bowel disease in the German population.
    Glas J; Seiderer J; Tillack C; Paschos E; Wetzke M; Diegelmann J; Czamara D; Brand S
    Inflamm Bowel Dis; 2011 Jun; 17(6):1439-40. PubMed ID: 21560203
    [No Abstract]   [Full Text] [Related]  

  • 26. Nutrigenomics and IBD: the intestinal microbiota at the cross-road between inflammation and metabolism.
    Haller D
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S6-9. PubMed ID: 20535026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.
    Fidder HH; Heijmans R; Chowers Y; Bar-Meir S; Avidan B; Pena AS; Crusius JB
    Int J Immunogenet; 2006 Apr; 33(2):81-5. PubMed ID: 16611251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics of inflammatory bowel disease: progress and prospects.
    Mathew CG; Lewis CM
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R161-8. PubMed ID: 14764625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease.
    Klein W; Tromm A; Griga T; Fricke H; Folwaczny C; Hocke M; Eitner K; Marx M; Runte M; Epplen JT
    Electrophoresis; 2000 Nov; 21(17):3578-82. PubMed ID: 11271474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The R30Q DLG5 variant is not associated with celiac disease or inflammatory bowel disease in the Spanish population.
    Dema B; Fernández-Arquero M; Maluenda C; Polanco I; Figueredo MA; De La Concha EG; Urcelay E; Núñez C
    Tissue Antigens; 2011 Jan; 77(1):62-4. PubMed ID: 20796250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
    Baumgart DC; Buning C; Geerdts L; Schmidt HH; Genschel J; Fiedler T; Gentz E; Molnar T; Nagy F; Lonovics J; Lochs H; Wiedenmann B; Nickel R; Witt H; Dignass A
    Digestion; 2007; 76(3-4):196-202. PubMed ID: 18174680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inflammatory bowel disease: genotype-fenotype relationship].
    Gómez de la Concha E
    An R Acad Nac Med (Madr); 2006; 123(2):307-17; discussion 318-20. PubMed ID: 17310638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research.
    Duerr RH
    Gastroenterology; 2007 May; 132(5):2045-9. PubMed ID: 17484895
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Yamamoto-Furusho JK; Fonseca-Camarillo G
    Inflamm Bowel Dis; 2015 Nov; 21(11):2683-95. PubMed ID: 26244649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of PPARG gene variants in inflammatory bowel disease.
    Glas J; Seiderer J; Markus C; Pfennig S; Wetzke M; Paschos E; Göke B; Ochsenkühn T; Müller-Myhsok B; Diegelmann J; Roeske D; Brand S
    Inflamm Bowel Dis; 2011 Apr; 17(4):1057-8. PubMed ID: 20722066
    [No Abstract]   [Full Text] [Related]  

  • 36. [Genome research on susceptibility loci in inflammatory bowel disease].
    Zheng CQ; Hu GZ
    Zhonghua Nei Ke Za Zhi; 2003 Sep; 42(9):660-2. PubMed ID: 14738050
    [No Abstract]   [Full Text] [Related]  

  • 37. [Genetics of inflammatory bowel disease].
    Kinouchi Y; Takahashi S; Endo K; Shiga H; Shimosegawa T
    Nihon Rinsho; 2012 Feb; 70 Suppl 1():66-72. PubMed ID: 23126069
    [No Abstract]   [Full Text] [Related]  

  • 38. Inflammatory bowel diseases 2003--from genetics to biological therapy.
    Schölmerich J
    Dig Dis; 2003; 21(2):83-4. PubMed ID: 14571106
    [No Abstract]   [Full Text] [Related]  

  • 39. Epigenomics: Deciphering non-coding variation with 3D epigenomics.
    Burgess DJ
    Nat Rev Genet; 2016 Dec; 18(1):4. PubMed ID: 27956750
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of the protein-tyrosine phosphatase nonreceptor type substrate 1 (PTPNS1) gene with inflammatory bowel disease.
    Roberts RL; Hollis-Moffatt JE; Gómez-García M; Fransen K; Ponsioen CY; Crusius BA; Wijmenga C; Martín J; Weersma RK; Merriman TR; Barclay ML; Gearry RB; Alizadeh BZ
    Inflamm Bowel Dis; 2011 Feb; 17(2):E19-21. PubMed ID: 21225905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.